C‑Terminal Plays as the Possible Nucleation of the Self-Aggregation of the S‑Shape Aβ11–42 Tetramer in Solution: Intensive MD Study

• Published in: ACS omega Vol. 4; no. 6; pp. 11066 - 11073
• Main Authors: Tung, Nguyen Thanh, Derreumaux, Philippe, Vu, Van V, Nam, Pham Cam, Ngo, Son Tung
• Format: Journal Article
• Language: English
• Published: American Chemical Society 30.06.2019
• ISSN: 2470-1343; 2470-1343
• DOI: 10.1021/acsomega.9b00992

Amyloid beta (Aβ) peptides are characterized as the major factors associated with neuron death in Alzheimer’s disease, which is listed as the most common form of neurodegeneration. Disordered Aβ peptides are released from proteolysis of the amyloid precursor protein. The Aβ self-assembly process roughly takes place via five steps: disordered forms → oligomers → photofibrils → mature fibrils → plaques. Although Aβ fibrils are often observed in patient brains, oligomers were recently indicated to be major neurotoxic elements. In this work, the neurotoxic compound S-shape Aβ11–42 tetramer (S4Aβ11–42) was investigated over 10 μs of unbiased MD simulations. In particular, the S4Aβ11–42 oligomer adopted a high dynamics structure, resulting in unsuccessful determination of their structures in experiments. The C-terminal was suggested as the possible nucleation of the Aβ42 aggregation. The sequences 27–35 and 39–40 formed rich β-content, whereas other residues mostly adopted coil structures. The mean value of the β-content over the equilibrium interval is ∼42 ± 3%. Furthermore, the dissociation free energy of the S4Aβ11–42 peptide was predicted using a biased sampling method. The obtained free energy is ΔG US = −58.44 kcal/mol which is roughly the same level as the corresponding value of the U-shape Aβ17‑42 peptide. We anticipate that the obtained S4Aβ11–42 structures could be used as targets for AD inhibitor screening over the in silico study.